Company profile: INW
1.1 - Company Overview
Company description
- Provider of manufacturing services for dietary supplements, sports nutrition, cosmetics, tablets, and other wellness products, producing powders (meal replacements, plant-based protein, vitamin herbal), capsules and tablets (amino acids, delayed release, multivitamins), soft gels (fish oil, omega-3), nutritional gels, functional beverages (energy shots, aloe vera), and bars.
Products and services
- Capsules / Tablets: Engineers industrial-grade dosage forms for dietary supplements and sports nutrition, including amino acid supplements, delayed release capsules, and multivitamin tablets
- Powders: Produces industrial-grade nutritional powders for dietary supplements and sports nutrition, including meal replacements, plant-based protein powders, and vitamin herbal powders
- Soft Gels: Fabricates industrial-grade soft gel capsules for various dietary supplements, including fish oil and omega-3 capsules used in wellness applications
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to INW
Curia
HQ: United States
Website
- Description: Provider of contract research, development, and manufacturing services for pharmaceutical and biopharmaceutical customers, covering discovery biology, synthetic and medicinal chemistry, and small-scale and commercial manufacturing. Formerly AMRI, Curia delivers offerings from R&D through commercial manufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Curia company profile →
Minakem
HQ: France
Website
- Description: Provider of pharmaceutical intermediates and active pharmaceutical ingredients for life sciences industries, offering API manufacturing for innovative and generic drugs, including highly potent APIs; custom development and manufacturing; production of key intermediates; comprehensive analytical services from substance development to marketing authorization; and corticosteroid API manufacturing at a Montreal facility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Minakem company profile →
ThreeWire
HQ: United States
Website
- Description: Provider of customized clinical trial recruitment, enrollment and retention solutions for the pharmaceutical, biotech and medical device industries, addressing enrollment targets and study delays, and offering direct-to-patient marketing services for medical device companies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ThreeWire company profile →
Dalton Pharma Services
HQ: Canada
Website
- Description: Provider of cGMP contract drug discovery, development, and manufacturing services to pharmaceutical and biotechnology industries. FDA-registered and Health Canada approved with over 30 years of experience. Offerings include cGMP API manufacturing, custom chemical synthesis, formulation development, sterile filling services, accelerated stability testing, and conjugation services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dalton Pharma Services company profile →
Accupac
HQ: United States
Website
- Description: Provider of integrated formulation, manufacturing, packaging, and procurement services for pharmaceutical and personal care products on an outsourced basis, offering project management from concept to commercialization, in-house analytical and microbiology testing, new product development via Cobalt Labs, and liquid/emulsion filling; batch sizes 100–19,000 KGS and 1.9B ounces capacity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Accupac company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for INW
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to INW
2.2 - Growth funds investing in similar companies to INW
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for INW
4.2 - Public trading comparable groups for INW
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →